03 November 2010
InVivo Therapeutics ~ Frank Reynolds @ MIT!
We had Frank Reynolds join us in MIT Neurotechnology Ventures today to share lessons from his experience in founding and building InVivo Therapeutics, developers of groundbreaking technologies to treat spinal cord injuries (SCI). Frank co-founded InVivo with Professor Bob Langer while pursuing his Sloan Fellows degree at MIT. Having personally suffered a spinal injury, he's passionate about accelerating effective neuro-treatments for both good and profit. This business went public last week (NVIV) which alone is pretty compelling. After showing pretty amazing results in monkeys, they're about to move from primate testing to human trials as soon as they get FDA approval. Interesting neuroco!